Stability of Oxycodone Solutions Containing S-Ketamine or Dexmedetomidine

This study demonstrates that oxycodone patient-controlled analgesia solutions compounded with S-ketamine or dexmedetomidine maintain microbiological, physical, and chemical stability for 28 days at refrigerated temperatures followed by 2 days at room temperature, supporting their centralized preparation and extended shelf-life in hospital pharmacy practice.

The Gist

Imagine you are a chef in a busy hospital kitchen. Your job is to prepare special "pain-relief soups" (medication) for patients who are in pain after surgery. These soups are usually made fresh, one pot at a time, right before they are served. This is safe, but it's also a lot of work, creates a lot of waste, and means the kitchen staff are constantly rushing.

Recently, doctors have started asking for a "super soup." They want to mix the main ingredient, Oxycodone (a strong painkiller), with two special spices: S-ketamine and Dexmedetomidine. These spices help the painkiller work better and allow patients to need less of the main ingredient.

However, there's a problem: You can't buy this "super soup" in a bottle at the store. The hospital pharmacy has to mix it themselves. Because it's a mix of different ingredients, nobody knew for sure if it would stay fresh and safe if they made a big batch ahead of time and stored it in the fridge. Would the spices settle at the bottom? Would the soup go bad? Would it grow invisible bacteria?

The Big Experiment
The scientists in this paper decided to play the role of "food safety inspectors." They wanted to see if they could make a big batch of these mixed pain soups, store them in special containers (called PCA reservoirs), and keep them safe for a month.

Here is what they did, using some fun analogies:

1. The "Time-Travel" Test

They made 42 containers of the soup.

• The Fridge Phase: They put them in a hospital fridge (2–8°C) for 28 days. This is like putting a sandwich in the fridge for a month to see if it stays fresh.
• The Room Temp Phase: After the month in the fridge, they took them out and left them on the counter (room temperature) for 2 days. This simulates the time a patient might carry the pump home or keep it on a bedside table.

2. The "Three-Point Safety Check"

To see if the soup was still good, they checked three things:

• The "Eye Test" (Physical Stability): Did the soup change color? Did it get cloudy? Did it form chunks?
  • The Result: Perfect. The soup looked exactly the same on Day 30 as it did on Day 1. No chunks, no color changes. It was as clear as a mountain stream.
• The "Bacteria Test" (Microbiological Stability): Did any tiny, invisible germs grow in the soup?
  • The Result: Zero germs. They tested the soup against six different types of "bad guys" (bacteria and fungi). The soup didn't stop the germs from growing (which is good, because it means the soup isn't toxic to the test), but more importantly, the soup itself stayed completely sterile. No bugs were found after 30 days.
• The "Chemical Test" (Chemical Stability): Did the ingredients break down or disappear?
  • The Result: Rock solid. They used a high-tech machine (like a very fancy microscope for chemicals) to measure the exact amount of Oxycodone, S-ketamine, and Dexmedetomidine. Even after a month, the amounts were still within 5% of what they started with. It's like if you bought a bag of 100 candies, and a month later, you still had 95 to 100 of them. Nothing had vanished or turned into something else.

3. The "Leaky Bucket" Check

They also weighed the containers. Since liquids can evaporate (turn into gas) over time, they wanted to make sure the soup didn't dry out too much.

• The Result: They lost less than 0.3% of the liquid weight. Imagine a full bucket of water losing just a few drops over a whole month. It was so little that it didn't matter at all.

The Big Takeaway

Before this study, hospital pharmacies had to be very cautious. They might have had to throw away mixed medication after just a few days because they weren't sure if it was safe.

This study proves that these "super soups" are safe to keep for 28 days in the fridge, plus 2 days on the counter.

Why does this matter?

• Efficiency: Instead of mixing one pot of soup every day for every patient, the pharmacy can mix a huge batch once a week.
• Less Waste: They won't have to throw away expired medication as often.
• Better Care: It frees up the pharmacists to focus on other things, ensuring that patients get their pain relief faster and more reliably.

In short, this paper is the "green light" for hospitals to start making these mixed pain medications in advance, knowing they will stay fresh, safe, and effective for a whole month. It's a win for the kitchen staff and a win for the patients.

Technical Summary

1. Problem Statement

Patient-controlled analgesia (PCA) is a standard for postoperative pain management, often enhanced by combining opioids with adjuvant agents like S-ketamine or dexmedetomidine to improve analgesia and reduce opioid consumption. However, no commercial multi-agent formulations exist for these combinations. Consequently, hospital pharmacies must prepare these mixtures as Compounded Sterile Preparations (CSPs).

The core problem addressed is the lack of systematic stability data for these specific combinations. Without validated data on chemical degradation, physical changes, and microbiological sterility, hospital pharmacies cannot confidently assign extended "beyond-use dates" (BUDs). This limitation forces pharmacies to prepare small batches frequently, increasing aseptic workload, reducing production efficiency, and potentially increasing medication waste.

2. Methodology

The study evaluated the chemical, physical, and microbiological stability of oxycodone PCA solutions mixed with S-ketamine or dexmedetomidine under clinically relevant conditions.

• Preparation: Solutions were compounded under validated EU GMP Class A/B aseptic conditions in a hospital pharmacy.
  • Base: Oxycodone hydrochloride trihydrate (1 mg/mL) in 0.9% sodium chloride.
  • Mixtures:
    • S-Ketamine: Three concentrations (0.25, 0.50, and 0.75 mg/mL).
    • Dexmedetomidine: Three concentrations (2.5, 5.0, and 10 µg/mL).
  • Packaging: Solutions were filled into PCA reservoirs (CADD-Legacy™).
• Storage Conditions:
  • Primary: 28 days at 2–8°C (refrigerated).
  • Secondary: 2 days at 20–25°C (room temperature) to simulate patient use.
• Analytical Methods:
  • Chemical Stability: A validated HPLC-UV method (reversed-phase) was developed according to FDA and ICH Q2(R1) guidelines to simultaneously quantify oxycodone, S-ketamine, and dexmedetomidine. No internal standard was used.
  • Physical Stability: Visual inspection (color, particles, precipitation), pH measurement, gravimetric weight loss, and osmolality.
  • Microbiological Stability:
    • Sterility: Membrane filtration (Ph. Eur. 2.6.1) on 21 reservoirs over 30 days.
    • Antimicrobial Activity: Method suitability tests using six reference strains (including S. aureus, P. aeruginosa, C. albicans, etc.) to ensure the drug mixtures did not inhibit bacterial growth, which could lead to false-negative sterility results.
• Sampling Schedule: Samples were analyzed on Days 0, 3, 7, 14, 21, 28, and 30.

3. Key Contributions

• Method Validation: The study successfully developed and validated a specific HPLC-UV method for the simultaneous determination of oxycodone, S-ketamine, and dexmedetomidine in saline, demonstrating linearity, accuracy, and precision within regulatory standards.
• Comprehensive Stability Profile: It provides the first comprehensive dataset covering chemical, physical, and microbiological stability for these specific opioid-adjuvant combinations in PCA reservoirs.
• Practical Workflow Data: The study specifically addresses the feasibility of centralized batch compounding, a critical operational need for hospital pharmacies.

4. Key Results

• Microbiological Stability:
  • Sterility: All 21 reservoirs remained sterile (free of turbidity) throughout the 30-day period.
  • Antimicrobial Interference: The drug mixtures showed no antimicrobial activity against the six reference strains, confirming that the sterility test results were reliable and not masked by drug inhibition.
• Physical Stability:
  • Appearance: No visual changes, precipitation, discoloration, or gas bubble formation were observed.
  • Weight Loss: Evaporation was minimal, with total weight loss ≤0.3% over the study period (accelerated slightly at room temperature but clinically insignificant).
  • pH: All pH values remained within the required range of 4.5–7.0.
  • Osmolality: Increased by less than 1.4%, which is considered insignificant.
• Chemical Stability:
  • Concentration: The concentrations of oxycodone, S-ketamine, and dexmedetomidine remained within ±5% of their initial values throughout the 30-day period.
  • Degradation: No degradation products or impurities were detected via HPLC-UV.
  • Specific Data: At Day 30, relative concentrations ranged from 95.80% (S-ketamine 0.75 mg/mL) to 104.64% (Oxycodone with 10 µg/mL dexmedetomidine).

5. Significance and Implications

• Extended Shelf-Life: The findings support assigning a 28-day beyond-use date for these compounded solutions when stored at 2–8°C, followed by an additional 2 days at room temperature.
• Operational Efficiency: These data enable hospital pharmacies to shift from just-in-time preparation to centralized batch compounding. This significantly reduces the aseptic workload, optimizes cleanroom utilization, and minimizes medication waste.
• Patient Safety: The study confirms that these complex mixtures maintain chemical integrity and sterility, ensuring that patients receive accurate dosages of both the opioid and the adjuvant throughout the treatment period.
• Regulatory Support: The study provides the necessary evidence base for hospital pharmacists to justify extended storage times to regulatory bodies and hospital quality assurance committees, aligning with EU GMP guidelines.

In conclusion, the study demonstrates that oxycodone PCA solutions combined with S-ketamine or dexmedetomidine are stable and safe for extended storage, facilitating more efficient and sustainable hospital pharmacy practices.